Q-linea strengthens management team

“In previous roles, Thomas Fritz has successfully driven results, both in terms of sales and profits, and I am pleased to welcome him to the Q-linea family. His experiences from both mature and emerging markets will be a big advantage for us at future launches in Europe and the US.” says Jonas Jarvius, CEO of Q-linea.

Thomas Fritz has over 20 years of experience in sales and marketing in the IVD industry (in vitro diagnostics), most recently as commercial manager for Microbiology at Thermo Fischer, EMEA, a unit with 200 employees and annual sales of $ 250 million. Thomas Fritz starts at Q-linea in September 2019. 

For more information, please contact:  
Jonas Jarvius, CEO, Q-linea AB  
Jonas.Jarvius@qlinea.com, 
+46 (0)70-323 77 60   

Anders Lundin, CFO, Q-linea AB  
Anders.Lundin@qlinea.com  
+46 (0)70-600 15 20 

The information was submitted for publication, through the agency of the contact persons set out above, at 09:00 CET on September 3, 2019.  

About Q-linea

Q-linea is an innovative research, development and manufacturing company that primarily develops instruments and disposables for rapid and reliable infection diagnostics. Q-linea’s vision is to help save lives by ensuring antibiotics continue to be an effective treatment for future generations. Q-linea develops and delivers preferred solutions for healthcare providers, enabling them to accurately diagnose and treat infectious disease in the shortest possible time. The company’s lead product ASTar™ is a fully automated instrument for antibiotic susceptibility testing (AST), giving a susceptibility profile within six hours directly from a positive blood culture. For more information, please visit www.qlinea.com.